Thomas Steuber

Thomas Steuber

Auto-generated profile, based on publicly available information

Thomas Steuber

Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2010 in BJU International
Verified
Journal Article
Open access
PDF file
TSThomas Steuber
Thomas Steuber
LBLars Budäus
Lars Budäus
JWJochen Walz
Jochen Walz
KZKevin C. Zorn
Kevin C. Zorn
TSThorsten Schlomm
Thorsten Schlomm
AHAlexander Haese
Alexander Haese
Study Type – Therapy (outcomes research) Level of Evidence 2b What’s known on the subject? and What does the study add? Historically, surgeons were reluctant to perform radical prostatectomy (RP) in LN positive disease. Nowadays, a shift towards multimodal treatment strategies in such patients, comprising RP with extended lymph node dissection followed by radiation and/or hormonal therapy can be detected. However, this change of paradigm is not supported by evidence derived from treatment guidelines. Retrospective studies on this topic, comprising small numbers of patients from the pre‐PSA era in the US suggest a survival advantage, if RP is performed. Our analyses of cancer control rates between patients with discontinued vs. completed prostatectomy revealed a superior clinical progression free‐ and cancer specific‐survival rate in those patients with completed prostatectomy. These results add knowledge on treatment outcome of a current patient population since previous retrospective studies include patients from the pre‐PSA era. OBJECTIVE: • To assess the prognostic role of radical prostatectomy (RP) in lymph node (LN) positive patients with prostate cancer (PCa) in a contemporary RP cohort. PATIENTS AND METHODS: • Between 1992 and 2004, 158 consecutive patients with clinically localized PCa and regional LN metastasis were identified. Fifty patients underwent LN dissection and discontinued RP, combined with early hormonal therapy (HT) (RP−), whereas, in 108 patients, RP was completed followed by adjunctive HT (RP+). • Clinical progression‐free‐ (CPFS) and cancer‐specific survival (CSS) were studied using Kaplan–Meier analysis. • Disease characteristics and the impact of RP on CPFS and CSS were further assessed using Cox proportional hazard models. • A matched pair analysis between RP− and RP+ patients was performed based on clinical and pathological factors. RESULTS: • Median follow‐up was 98 months (interquartile range, 88–113). Five‐ and 10‐year CPFS was 77% and 61% for RP+ patients vs 61% and 31%, for RP− patients ( P = 0.005), respectively. • A similar trend was observed for CSS (84% and 76% for RP+ vs 81% and 46% for RP−; P = 0.001). • Type of treatment (RP− vs RP+) and number of positive LN were multivariate predictors of CPFS and CSS (all P ≤ 0.05). • In the matched pair analyses, RP+ patients showed superior CPFS and CSS ( P < 0.005). CONCLUSIONS: • RP had a beneficial impact, resulting in the superior survival of patients with LN positive PCa after controlling for LN tumour burden in a contemporary RP series. • The findings obtained in the present study support the role of RP as an important component of multimodal strategies of LN positive PCa.

29 March 2019 in BJU International
Verified
Journal Article
Closed access
PDF file
AHAlexander Haese
Alexander Haese
SKSophie Knipper
Sophie Knipper
HIHendrik Isbarn
Hendrik Isbarn
HHHans Heinzer
Hans Heinzer
DTDerya Tilki
Derya Tilki
MGMarkus Graefen
Markus Graefen

1 December 2017 in European Urology Focus
Verified
Journal Article
Closed access
TSThomas Steuber
Thomas Steuber
KBKasper D. Berg
Kasper D. Berg
Martin Andreas RøderMartin Andreas Røder
Martin Andreas Røder
KBKlaus Brasso
Klaus Brasso
PIPeter Iversen
Peter Iversen
PMPhilipp Mandel
Philipp Mandel

1 May 2016 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
CMChristian P. Meyer
Christian P. Meyer
KPKlaus Pantel
Klaus Pantel
PTPierre Tennstedt
Pierre Tennstedt
PSPetra Stroelin
Petra Stroelin
TSThorsten Schlomm
Thorsten Schlomm
TSThomas Steuber
Thomas Steuber

1 January 2021 in European Urology Focus
Verified
Journal Article
Closed access
PMPhilipp C. Mandel
Philipp C. Mandel
HHHartwig Huland
Hartwig Huland
ATAnne Tiebel
Anne Tiebel
AHAlexander Haese
Alexander Haese
GSGeorg Salomon
Georg Salomon
TSThomas Steuber
Thomas Steuber

1 January 2010 in European Journal of Cancer
Verified
Journal Article
Closed access
TST. Steuber
T. Steuber
TST. Schlomm
T. Schlomm
HHH. Heinzer
H. Heinzer
MZM. Zacharias
M. Zacharias
SAS. Ahyai
S. Ahyai
GSG. Salomon
G. Salomon